BIBLIOGRAFIA


3.
Randrup
A:
Role
of
brain
dopamine
in
the
antipsychotic
effect
of
neuroleptics.
 Evidence
 from
 studies
 of
 amphetamine‐neuroleptic
 interaction.
 Mod
 Probl
 Pharmacopsychiatry
1970,
5:60‐65.


4.
Meyer‐Lindenberg
A,
Miletich
RS,
Kohn
PD,
Esposito
G,
Carson
RE,
Quarantelli
 M,
Weinberger
DR,
Berman
KF:
Reduced
prefrontal
activity
predicts
exaggerated
 striatal
 dopaminergic
 function
 in
 schizophrenia.
 Nat
 Neurosci
 2002,
 5(3):267‐ 271.


5.
 Perlstein
 WM,
 Dixit
 NK,
 Carter
 CS,
 Noll
 DC,
 Cohen
 JD:
 Prefrontal
 cortex
 dysfunction
mediates
deficits
in
working
memory
and
prepotent
responding
in
 schizophrenia.
Biol
Psychiatry
2003,
53(1):25‐38.


6.
 Seamans
 JK,
 Yang
 CR:
 The
 principal
 features
 and
 mechanisms
 of
 dopamine
 modulation
in
the
prefrontal
cortex.
Prog
Neurobiol
2004,
74(1):1‐58.


7.
 Weiner
 I:
 The
 "two‐headed"
 latent
 inhibition
 model
 of
 schizophrenia:
 modeling
 positive
 and
 negative
 symptoms
 and
 their
 treatment.
 Psychopharmacology
2003,
169(3‐4):257‐297.


8.
 Ben‐Shachar
 D,
 Laifenfeld
 D:
 Mitochondria,
 synaptic
 plasticity,
 and
 schizophrenia.
Int
Rev
Neurobiol
2004,
59:273‐296.



 9.
O'Tuathaigh
C
M,
Babovic
D,
O'Meara
G,
Clifford
JJ,
Croke
DT,
Waddington
JL:
 Susceptibility
genes
for
schizophrenia:
Characterisation
of
mutant
mouse
models
 at
the
level
of
phenotypic
behaviour.
Neurosci
Biobehav
Rev
2006.
 
 10.
Maier
W,
Zobel
A,
Kuhn
KU:
Clinical
impact
of
recently
detected
susceptibility
 genes
for
schizophrenia.
Dialogues
Clin
Neurosci
2006,
8(1):79‐84.
 
 11.
Isohanni
M,
Lauronen
E,
Moilanen
K,
Isohanni
I,
Kemppainen
L,
Koponen
H,
 Miettunen
 J,
 Maki
 P,
 Rasanen
 S,
 Veijola
 J,
 Tienari
 P,
 Wahlberg
 KE,
 Murray
 GK:
 Predictors
 of
 schizophrenia:
 evidence
 from
 the
 Northern
 Finland
 1966
 Birth
 Cohort
and
other
sources.
Br
J
Psychiatry
Suppl
2005,
48:s4‐7.


12.
 Gottesman
 II,
 Gould
 TD:
 The
 endophenotype
 concept
 in
 psychiatry:
 etymology
and
strategic
intentions.
Am
J
Psychiatry
2003,
160(4):636‐645.


13.
 Berrettini
 WH:
 Genetic
 bases
 for
 endophenotypes
 in
 psychiatric
 disorders.
 Dialogues
Clin
Neurosci
2005,
7(2):95‐101.


14.
Bowden
NA,
Weidenhofer
J,
Scott
RJ,
Schall
U,
Todd
J,
Michie
PT,
Tooney
PA:
 Preliminary
 investigation
 of
 gene
 expression
 profiles
 in
 peripheral
 blood
 lymphocytes
in
schizophrenia.
Schizophr
Res
2006,
82(2‐3):175‐183.


15.
 Baldridge
 EB,
 Bessen
 HA:
 Phencyclidine.
 Emerg
 Med
 Clin
 North
 Am
 1990,
 8(3):541‐550.


16.
Huang
JT‐J,
Leweke
FM,
Tsang
TM,
Koethe
D,
Kranaster
L,
et
al
(2007)
CSF
 Metabolic
and
Proteomic
Profiles
in
Patients
Prodromal
for
Psychosis.
PLoS
ONE
 2(8):
e756.


17.
 Coelho
 FM,
 Reis
 HJ,
 Nicolato
 R,
 Romano‐Silva
 MA,
 Teixeira
 MM,
 Bauer
 ME,
 Teixeira
 AL:
 Increased
 serum
 levels
 of
 inflammatory
 markers
 in
 chronic


institutionalized
 patients
 with
 schizophrenia.
 Neuroimmunomodulation
 2008,
 15:140‐4


18.
Dietrich‐Muszalska
A,
Olas
B:
The
changes
of
aggregability
of
blood
platelets
 in
schizophrenia.
World
J
Biol
Psychiatry
:1‐6.
2007,
Sep
14


19.
 Dietrich‐Muszalska
 A,
 Olas
 B,
 Rabe‐Jablonska
 J:
 Oxidative
 stress
 in
 blood
 platelets
from
schizophrenic
patients.
Platelets
2005,
16:386‐91.


20.
Porton
B,
Delisi
LE,
Bertisch
HC,
Ji
F,
Gordon
D,
Li
P,
Benedict
MM,
Greenberg
 WM,
Kao
HT:
Telomerase
levels
in
schizophrenia:
A
preliminary
study.
Schizophr
 Res
2008,
106:242‐7.


21.
 Craddock
 RM
 et
 al.
 Increased
 alpha‐defensins
 as
 a
 blood‐marker
 for
 schizophrenia
susceptibility.
Molecular
and
Cellular
Proteomics,
2008.


22.
 Martins‐de‐Souza
 D,
 Maccarrone
 G,
 Wobrock
 T,
 Zerr
 I,
 Gormanns
 P
 et
 al
 (2010)
 Proteome
 analysis
 of
 the
 thalamus
 and
 cerebrospinal
 fluid
 reveals
 glycolysis
 dysfunction
 and
 potential
 biomarkers
 for
 schizophrenia.
 J
 Neurosci
 (submitted)
 
 23.
McLoughlin
GA,
Ma
D,
Tsang
TM,
Jones
DN,
Cilia
J
et
al
(2009)
Analyzing
the
 effects
of
psychotropic
drugs
on
metabolite
profiles
in
rat
brain
using
1H
NMR
 spectroscopy.
J
Proteome
Res
8(4):1943–1952
 


24.
 Ditzen
 C,
 Varadarajulu
 J,
 Czibere
 L,
 Gonik
 M,
 Targosz
 BS
 et
 al
 (2009)
 Proteomic‐based
genotyping
in
a
mouse
model
of
trait
anxiety
exposes
disease‐ relevant
pathways.
Mol
Psychiatry
[Epub
ahead
of
print]


25.
Salim
K,
Kehoe
L,
Minkoff
MS,
Bilsland
JG,
Munoz‐Sanjuan
I,
Guest
PC
(2006)
 Identification
 of
 differentiating
 neural
 progenitor
 cell
 markers
 using
 shotgun
 isobaric
tagging
mass
spectrometry.
Stem
Cells
Dev
15(3):461–470


of
the
beginning”.
Nature
Neuroscience
2004;
5
(7):
440‐445.
 
 27.
Godovac‐Zimmermann
J,
Soskic
V,
Poznanovic
S,
Brianza
F.
“Functional
 proteomics
of
signal
transduction
by
membrane
receptors”.
Electrophoresis
 1999;
20
(4‐5):
952‐961.
 
 28.
Imam‐Sghiouar
N,
Laude‐Lemaire
I,
Labas
V,
Pflieger
D,
Le
Caer
JP,
Caron
M,
 Nabias
DK,
Joubert‐Caron
R.
“Subproteomics
analysis
of
phosphorylated
 proteins:
application
to
the
study
of
B‐lymphoblast
from
a
patient
with
Scott
 syndrome”.
Proteomics
2002;
2
(7):
828‐838.
 
 29.
Phizicky
E,
Bastiaens
PI,
Zhu
H,
Snyder
M,
Fields
S.
“Protein
analysis
on
a
 proteomic
scale”.
Nature
2003;
422:
208‐215.
 
 30.
Pandey
A,
Mann
M.
“Proteomics
to
study
genes
and
genomes”.
Nature
2000;
 405:
837‐846.
 
 31.
Herbert
BR
et
al.
“What
place
for
polyacrylamide
in
proteomics?”.
Trends
 Biotechnol
2001;
19:
S3‐S9.
 
 32.
Graves
PR,
Haystead
TAJ.
“Molecoular
biologist’s
guide
to
proteomics”.
 Microbiol
Mol
Biol
Rev
2002;
66:
39‐46.
 
 33.
Gorg
A,
Postel
W,
Gunther
S.
“The
current
state
of
two‐dimensional
 electrophoresis
with
immobilized
pH
gradients”.
Electrophoresis
1988;
9
 (9):
531‐546.
 
 34.
Lewis
TS,
Hunt
JB,
Aveline
LD,
Jonscher
KR,
Louie
DF,
Yeh
JM,
Nahreini
TS,
 Resing
KA,
Ahn
NG.
“Identification
of
novel
MAP
kinase
pathway
signalling
 targets
by
functional
proteomics
and
mass
spectrometry”.
Mol
Cell
2000;
6:
 1343‐1354.
113
 
 35.
Graves
PR,
Haystead
TAJ.
“A
functional
proteomics
approach
to
signal


transduction”.
Recent
Prog
Horm
Res
2003;
58:
1‐24.
 
 36.
Soskic
V,
Gorlach
M,
Poznanovic
S,
Boehmer
FD,
Godovac‐
Zimmermann
J.
 “Functional
proteomics
analysis
of
signal
transduction
pathways
of
the
platelet‐ derived
growth
factor
β
receptor”.
Biochemistry
1999;
38:
1757‐1764.
 
 37.
Jimenez
CR,
Li
KW,
Dreisewerd
K,
Spijker
S,
Kingston
R,
Bateman
RH
et
al.
 “Direct
mass
spectrometric
peptide
profiling
and
sequencing
of
single
neurons
 reveals
differential
peptide
patterns
in
a
small
neuronal
network”.
Biochemistry
 1998;
37:
2070‐2076.
 
 38.
Berkelman
T,
Stenstedt
T.
“2‐D
Electrophoresis,
using
immobilized
pH
 gradients.
Principles
and
Methods”.
Amersham
Biosciences
2002;
17‐22.
 
 39.
Klose
J.
“Protein
mapping
by
combined
isoeletric
focusing
and
 elettrophoresis
of
mouse
tissues.
A
novel
approach
to
testing
for
induced
point
 mutation
in
mammals”.
Humangenetik
1975;
26:
231‐243.
 
 40.
Gorg
A,
Postel
W,
Gunther
S,
Weser
J.
“Improved
horizontal
twodimensional
 electrophoresis
with
hybrid
isoelectric
focusing
in
immobilized
pH
gradients
in
 the
first
dimension
and
laying‐on
transfer
to
the
second
dimension”.
 Electrophoresis
1985;
6:
599‐604.
 
 41.
Sanchez
JC,
Rouge
V,
Pisteur
M,
Ravier
F,
Tonella
L,
Moosmayer
M,
Wilkins
 MR,
Hochstrasser
DF.
“Improved
and
simplified
in‐gel
sample
application
using
 reswelling
of
dry
immobilized
pH
gradients”.
Electrophoresis
1997;
18:
324‐327.
 114
 
 42.
Candiano
G,
Bruschi
M,
Musante
L,
Santucci
L,
Ghiggeri
GM,
Carnemolla
B,
 Orecchia
P,
Zardi
L,
Righetti
PG.
“Blue
silver:
a
very
sensitive
colloidal
Coomassie
 G‐250
staining
for
proteome
analysis”.
Electrophoresis
2004;
25:
1327‐1333.
 
 43.
Wilkins
MR,
Williams
KL,
Appeal
RD,
Hochstrasser
DF.
“Proteome
research:


new
frontiers
in
functional
genomics”.
Springer
Verlag,
Berlin,
Heidelberg
1997;
 1‐12.
 
 44.
Bonk
T,
Humeny
A.
“MALDI‐TOF‐MS
Analysis
of
Protein
and
DNA”.
The
 Neuroscientist
2001;
1
(7):
6‐12.
 
 45.
Langen
H,
Berndt
P,
Roder
D,
Cairns
N,
Lubec
G,
Fountoulakis
M.
“Two‐ dimensional
map
of
human
brain
proteins”.
Electrophoresis
1999;
20:
907‐916.
 
 46.
Husi
H,
Grant
SGN.
“Proteomics
of
the
nervous
system”.
Trends
in
 Neurosciences
2001;
5
(24):
259‐266.
 
 47.
Wilm
M,
Shevchenko
A,
Houthaeve
T,
Breit
S,
Schweigerer
L,
Fotsis
T,
Mann
 M.
“Femtomole
sequencing
of
proteins
from
polyacrylamide
gels
by
nano‐ electrospray
mass
spectrometry”.
Nature
1996;
379:
466‐469.